Pui-Wah Tse - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Pui-Wah Tse

Showing results (21-30 of 24) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 24 results.

Proceedings of the National Academy of Sciences of the United States of America|August 1, 2022

CFI-402257, a TTK inhibitor, effectively suppresses hepatocellular carcinomaCerise Yuen-Ki Chan, David Kung-Chun Chiu, Vincent Wai-Hin Yuen, et al.

Hepatology (Baltimore, Md.)|March 18, 2022

Polo-like kinase 4 inhibitor CFI-400945 suppresses liver cancer through cell cycle perturbation and eliciting antitumor immunityCerise Yuen-Ki Chan, Vincent Wai-Hin Yuen, David Kung-Chun Chiu, et al.

Science Advances|May 5, 2023

Hypoxia-inducible factor orchestrates adenosine metabolism to promote liver cancer developmentJacinth Wing-Sum Cheu, David Kung-Chun Chiu, Kenneth Kin-Leung Kwan, et al.

Cell Reports. Medicine|April 30, 2026

BCAT1-dependent HIF-1α stabilization is a targetable metabolic vulnerability in hepatocellular carcinomaMisty Shuo Zhang, Kenneth Kin-Leung Kwan, Aki Pui-Wah Tse, et al.

Pageof 3

Search research articles

Showing results (21-30 of 24) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 24 results.

Proceedings of the National Academy of Sciences of the United States of America|August 1, 2022

CFI-402257, a TTK inhibitor, effectively suppresses hepatocellular carcinomaCerise Yuen-Ki Chan, David Kung-Chun Chiu, Vincent Wai-Hin Yuen, et al.

Hepatology (Baltimore, Md.)|March 18, 2022

Polo-like kinase 4 inhibitor CFI-400945 suppresses liver cancer through cell cycle perturbation and eliciting antitumor immunityCerise Yuen-Ki Chan, Vincent Wai-Hin Yuen, David Kung-Chun Chiu, et al.

Science Advances|May 5, 2023

Hypoxia-inducible factor orchestrates adenosine metabolism to promote liver cancer developmentJacinth Wing-Sum Cheu, David Kung-Chun Chiu, Kenneth Kin-Leung Kwan, et al.

Cell Reports. Medicine|April 30, 2026

BCAT1-dependent HIF-1α stabilization is a targetable metabolic vulnerability in hepatocellular carcinomaMisty Shuo Zhang, Kenneth Kin-Leung Kwan, Aki Pui-Wah Tse, et al.

Pageof 3